THE BROAD INSTITUTE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8187
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 76179
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7156
 
  
 
C07D HETEROCYCLIC COMPOUNDS 27135
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 23183
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 16122
 
  
 
C07K PEPTIDES 14122
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1287
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 10437
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS939

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0072,671 INHIBITORS OF HISTONE DEACETYLASEAug 16, 17Mar 15, 18[A61K, C07D, C07C]
2018/0044,662 USE AND PRODUCTION OF CHD8+/- TRANSGENIC ANIMALS WITH BEHAVIORAL PHENOTYPES CHARACTERISTIC OF AUTISM SPECTRUM DISORDERMar 23, 17Feb 15, 18[C12N]
2018/0030,515 Droplet-Based Method And Apparatus For Composite Single-Cell Nucleic Acid AnalysisMar 08, 17Feb 01, 18[C12Q, C12N, G06K]
2017/0349,894 ESCORTED AND FUNCTIONALIZED GUIDES FOR CRISPR-CAS SYSTEMSJun 12, 17Dec 07, 17[A61K, C12Q, C12N]
2017/0349,914 DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs)Jun 12, 17Dec 07, 17[A61K, C12N]
2017/0349,950 T CELL BALANCE GENE EXPRESSION, COMPOSITIONS OF MATTERS AND METHODS OF USE THEREOFAug 25, 17Dec 07, 17[C12Q, G01N]
2017/0343,553 CANCER-RELATED EXTRACELLULAR MATRIX SIGNATURES AND RELATED METHODS AND PRODUCTSSep 22, 16Nov 30, 17[A61K, G01N]
2017/0334,842 INHIBITORS OF THE MITF MOLECULAR PATHWAYJul 07, 17Nov 23, 17[A61K, C07D, C07C]
2017/0321,214 DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORSJun 12, 17Nov 09, 17[A61K, C12Q, C12N, A01K]
2017/0321,284 CLONAL HAEMATOPOIESISNov 23, 15Nov 09, 17[A61K, C12Q]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914717 Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitorsDec 19, 13Mar 13, 18[C07D, C07C]
9901631 Method and cells for the production of viral vaccinesJan 10, 13Feb 27, 18[A61K, C12Q, C12N, A01K]
9890127 Compounds and compositions for the treatment of cancerMar 11, 14Feb 13, 18[A61K, C07D]
9890172 Inhibitors of histone deacetylaseMay 05, 16Feb 13, 18[A61K, C07D, C07C]
9890429 Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancerFeb 28, 13Feb 13, 18[A61K, C12Q, G01N, G06F]
9884851 Heterocycle-bisamide inhibitors of scavenger receptor BIOct 21, 13Feb 06, 18[C07D]
9885088 Rapid phenotypic diagnosis of pathogens and drug resistance using transcriptional expression signaturesFeb 24, 11Feb 06, 18[C12Q]
9856509 Fluorescent substrates for determining lysine modifying enzyme activityMay 01, 14Jan 02, 18[C09K, C12Q, C07D, C12N, C07K]
9840713 CRISPR-Cas component systems, methods and compositions for sequence manipulationOct 24, 14Dec 12, 17[C12N, A01H]
9834791 CRISPR-related methods and compositions with governing gRNASNov 07, 14Dec 05, 17[A61K, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0224,700 USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORSAbandonedAug 08, 15Aug 10, 17[A61K]
2016/0288,111 Method For Synthesising Esters And Catalyst For Said SynthesisAbandonedNov 06, 14Oct 06, 16[C07F, C07C, B01J]
2016/0115,489 CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATIONAbandonedJan 08, 16Apr 28, 16[C12N]
2016/0091,485 MARKERS FOR EZH2 INHIBITORSAbandonedApr 11, 14Mar 31, 16[G01N]
2016/0060,699 SLE AND SLE-RELATED DISEASE-ASSOCIATED RISK MARKERS AND USES THEREOFAbandonedApr 11, 14Mar 03, 16[C12Q]
2016/0031,874 SUBSTITUTED AMINOTHIAZOLES FOR THE TREATMENT OF TUBERCULOSISAbandonedMar 13, 14Feb 04, 16[C07D]
2016/0032,397 MAST CELL CANCER-ASSOCIATED GERM-LINE RISK MARKERS AND USES THEREOFAbandonedMar 13, 14Feb 04, 16[C12Q]
2016/0024,588 OSTEOSARCOMA-ASSOCIATED RISK MARKERS AND USES THEREOFAbandonedMar 14, 14Jan 28, 16[C12Q]
2015/0376,702 METHODS FOR ASSESSING THE RISK OF CANINE ATOPIC DERMATITISAbandonedFeb 21, 14Dec 31, 15[C12Q]
2015/0354,006 MARKERS FOR ACUTE LYMPHOBLASTIC LEUKEMIAAbandonedOct 15, 13Dec 10, 15[C12Q, G01N]
2015/0338,425 TREATMENT AND PROGNOSIS OF LYMPHANGIOLEIOMYOMATOSISAbandonedNov 14, 12Nov 26, 15[A61K, G01N]
2015/0322,528 BIOMARKERS ASSOCIATED WITH CDK INHIBITORSAbandonedJun 26, 13Nov 12, 15[A61K, C12Q, G01N]
2015/0299,795 CANCER-ASSOCIATED GERM-LINE AND SOMATIC MARKERS AND USES THEREOFAbandonedMay 30, 13Oct 22, 15[C12Q]
2015/0291,966 INDUCIBLE DNA BINDING PROTEINS AND GENOME PERTURBATION TOOLS AND APPLICATIONS THEREOFAbandonedJan 23, 15Oct 15, 15[C12N]
2015/0259,674 COMPOSITIONS AND METHODS FOR LONG INSERT, PAIRED END LIBRARIES OF NUCLEIC ACIDS IN EMULSION DROPLETSAbandonedMar 20, 15Sep 17, 15[C12N]
2015/0203,872 CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTSAbandonedApr 08, 15Jul 23, 15[C12N]
2015/0203,900 Methods of Diagnosing Infectious Disease Pathogens and Their Drug SensitivityAbandonedMar 09, 15Jul 23, 15[C12Q]
2015/0184,139 CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTSAbandonedJul 07, 14Jul 02, 15[C12N]
2015/0031,134 CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATIONAbandonedSep 26, 14Jan 29, 15[C12N]
2015/0020,223 DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONSAbandonedSep 09, 14Jan 15, 15[A01K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.